Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 259-470-2 | CAS number: 55067-15-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 10 March 2017 - 8 February 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- 29 Jul 2016
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- 30 May 2008
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5395 (In Vivo Mammalian Cytogenetics Tests: Erythrocyte Micronucleus Assay)
- Version / remarks:
- Aug 1998
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- BASF SE Experimental Toxicology and Ecology, 67056 Ludwigshafen, Germany
- Type of assay:
- other: micronucleus assay
Test material
- Reference substance name:
- 2-[4-[[2-(cyanoimino)hexahydro-4,6-dioxo-5-pyrimidyl]azo]phenyl]-6-methylbenzothiazole-7-sulphonic acid, compound with 2,2',2''-nitrilotris[ethanol] (1:1)
- EC Number:
- 259-470-2
- EC Name:
- 2-[4-[[2-(cyanoimino)hexahydro-4,6-dioxo-5-pyrimidyl]azo]phenyl]-6-methylbenzothiazole-7-sulphonic acid, compound with 2,2',2''-nitrilotris[ethanol] (1:1)
- Cas Number:
- 55067-15-7
- Molecular formula:
- C19 H13 N7 O5 S2 . C6 H15 N O3
- IUPAC Name:
- 2-[4-[[2-(cyanoimino)hexahydro-4,6-dioxo-5-pyrimidyl]azo]phenyl]-6-methylbenzothiazole-7-sulphonic acid, compound with 2,2',2''-nitrilotris[ethanol] (1:1)
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: 0013974305
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: room temperature
- Stability under test conditions: The stability of the test substance under storage conditions throughout the study was guaranteed until August 2019
Test animals
- Species:
- mouse
- Strain:
- other: Crl:NMRI
- Details on species / strain selection:
- The animals were selected according to the recommendations of the OECD and EU or on the basis of results published so far. Moreover, there has been up to now most experience and data for NMRI mice.
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories Germany GmbH
- Age at study initiation: 5 – 8 weeks
- Weight at study initiation: mean: 28.1 ± 1.46 g
- Assigned to test groups randomly: yes
- Fasting period before study: no
- Housing: Polycarbonate cages, type II; single housing
- Diet: ad libitum, Standardized pelleted feed (Maus/Ratte Haltung "GLP", Provimi Kliba SA, Kaiseraugst, Switzerland)
- Water: ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24
- Humidity (%): 30 - 70
- Air changes (per hr): Fully air-conditioned rooms with central air conditioning.
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- Vehicle(s)/solvent(s) used: water
- Justification for choice of solvent/vehicle:
Using the vehicle deionized water a homogeneous suspension of the test substance was obtained. Therefore, deionized water was used as vehicle, which has been demonstrated to be suitable in the mouse micronucleus test and for which historical control data are available.
- Concentration of test material in vehicle: 25, 50 and 100 mg/mL
- Amount of vehicle: 20 mL/kg bw - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
The substance to be administered per kg body weight was suspended in deionized water. To achieve the homogeneity of the test substance in the vehicle, the test substance preparation was treated with ultrasonic waves and shaken thoroughly. All test substance formulations were prepared immediately before administration. - Duration of treatment / exposure:
- 24 hours (1st group) and 48 hours (2nd group)
- Frequency of treatment:
- once
- Post exposure period:
- none
Doses / concentrationsopen allclose all
- Dose / conc.:
- 500 mg/kg bw/day (nominal)
- Dose / conc.:
- 1 000 mg/kg bw/day (nominal)
- Dose / conc.:
- 2 000 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide (CPP)
- Justification for choice of positive control(s): CPP is a well-established reference clastogen.
- Route of administration: oral (gavage)
- Final Concentration: 2 mg/mL
Examinations
- Tissues and cell types examined:
- femura prepared to obtain erythrocytes from bone marrow
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
Pretests were performed for dose selection.
The pretest was performed following the method described for the main experiment. The test substance was administered by gavage (orally) to NMRI mice of both sexes, three animals per dose and sex, in general. Then, the animals were examined for clinically evident signs of toxicity several times. About 48 hours after administration the surviving animals were sacrificed humanely by isoflurane anesthesia followed by cervical dislocation. In the pretest to determine the acute oral toxicity in males and females, the recommended highest dose of 2000 mg/kg body weight was tolerated by all animals without signs of toxicity. Feces discolored by the orange colored test substance was observed 4 hours and one day after administration. Besides, there was no indication for a gender specific toxicity. The usual application volume of 10 mL/kg body weight led to a non-applicable mass and therefore the volume was increased to 20 mL/kg body weight.
DETAILS OF SLIDE PREPARATION:
- The bone marrow suspension was mixed gently before transferring to the cellulose column. As soon as the suspension was fully soaked into the cellulose column 5 mL HBSS was added.
- The eluate containing erythrocytes was centrifuged at 300 x g for 5 minutes. The supernatant was removed gently and the precipitate was resuspended with 1 - 4 mL PBS
(Phosphate Buffered Saline with Ca and Mg) depending on the cell count.
- Labeled slides equipped with cell funnels were clamped into the rotor of the cytospin. Then, 200 μL cell suspension was transferred to each cell funnel and was centrifuged at 1 200 rpm (approx. 220 x g) for 7 minutes (at least two slides per animal).
- After drying the slides were stained with eosin and methylene blue (modified May-Grünwald solution or Wrights solution) for about 5 minutes.
- After briefly rinsing in deionized water, the preparations were soaked in deionized water for about 2 - 3 minutes.
- Subsequently, the slides were stained with Giemsa solution (15 mL Giemsa plus 185 mL deionized water) for about 15 minutes.
- After rinsing twice in deionized water and clarifying in xylene, the preparations were mounted in Corbit-Balsam.
METHOD OF ANALYSIS:
The slides for the evaluation of micronucleated erythrocytes were analyzed by use of the image analysis system Metafer4 MetaCyte (MetaSystems Hard & Software GmbH, Altlussheim, Germany). Polychromatic and normochromatic erythrocytes (PCE or NCE) that fulfill the criteria for scoring were automatically detected under the light microscope and were recorded by the system. Then, a trained scorer performed manually the analysis based on these preselected images on the screen. In case of low quality of images, e.g. artefacts of staining etc., the cells were assessed directly on the slides by light microscopy.
In general, 4000 polychromatic erythrocytes (PCE) were evaluated for the occurrence of micronuclei from each animal of every test group, so in total 20000 PCE were scored per test group. The normochromatic erythrocytes (= normocytes / NCE) were also scored. The following parameters were recorded:
• Number of polychromatic erythrocytes
• Number of polychromatic erythrocytes containing micronuclei
The increase in the number of micronuclei in polychromatic erythrocytes of treated animals as compared with the vehicle control group provides an index of a chromosome-breaking (clastogenic) effect or damage of the mitotic apparatus (aneugenic activity) of the test substance administered.
• Number of normochromatic erythrocytes
• Number of normochromatic erythrocytes containing micronuclei
The number of micronuclei in normochromatic erythrocytes at the early sacrifice interval shows the situation before test substance administration and may serve as a control value. A test substance induced increase in the number of micronuclei in normocytes may be found with an increase in the duration of the sacrifice interval.
• Ratio of polychromatic to normochromatic erythrocytes
An alteration of this ratio indicates that the test substance actually reached the bone marrow, means the target determined for genotoxic effects. The microscopic analysis was run on coded slides. - Evaluation criteria:
- A finding is considered positive if all of the following criteria are met:
• A statistically significant and dose-related increase in the number of PCE containing micronuclei.
• The number of polychromatic erythrocytes containing micronuclei has to exceed both the concurrent vehicle control value and the range of the historical vehicle control data (95% control limit).
A test substance is considered negative if the following criteria are met:
• The number of polychromatic erythrocytes containing micronuclei in the dose groups is not
statistically significant increased above the concurrent vehicle control value and is within the range of the historical vehicle control data (95% control limit).
A scientific judgment is required in case of equivocal data. - Statistics:
- For analysis of the rate of micronucleated polychromatic erythrocytes the Jonckheere-Terpstra test were used which is a non-parametric trend test. In addition, a pair-wise comparison of each test group with the control group was carried out using the Wilcoxon test (one-sided+). The statistical unit is the animal and, therefore, the rate per animal was used. The calculation was performed using R. The results were listed in the tables. If the results of these tests were significant, symbols (* for p ≤ 0.05; ** for p ≤ 0.01) were used in the tables. However, both biological relevance and statistical significance were considered together.
Results and discussion
Test results
- Key result
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- inhibition of erythropoiesis induced by the treatment with the test item was detected from 2000 mg/kg body weight at 24-hour sacrifice interval
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Clinical signs of toxicity in test animals:
In the pretest the recommended highest dose of 2000 mg/kg body weight was tolerated by all animals without signs of toxicity. Feces discolored by the orange colored test substance was observed 4 hours and one day after administration. Besides, there was no indication for a gender specific toxicity.
- Evidence of cytotoxicity in tissue analyzed: no
- Harvest times: 48 hours
- High dose with and without activation: 2000 mg/kg bw
RESULTS OF DEFINITIVE STUDY
- Induction of micronuclei: No. The rate of micronuclei in all dose groups and at all sacrifice intervals (0.5 – 3.3‰) was within the range of the concurrent vehicle controls (1.0 – 3.3‰), and all values were within the range of the 95% control limit of our historical vehicle control data (1.3 – 4.4‰).
- Ratio of PCE/NCE: see table 1
- Appropriateness of dose levels and route: Yes
- Statistical evaluation: Yes
OTHER:
The concentration control analyses of all concentrations revealed that the values were in the expected range of the target concentrations, i.e. were always in a range of 90% - 110% of the nominal concentration.
Distinct organ toxicity indicated by an inhibition of erythropoiesis induced by the treatment with the test item was detected from 2000 mg/kg body weight at 24-hour sacrifice interval.
The ratio of PCE to NCE was clearly influenced after treatment with 2000 mg/kg body weight (67% of control, respectively) compared to the concurrent vehicle control value. Animal weights were not relevantly influenced by test substance exposure compared to the respective vehicle control animals.
Any other information on results incl. tables
Table 1: Summary table - Induction of Micronuclei in bone marrow cells
Test group |
Sacrifice [hrs] |
Animal |
Micronuclei in PCE
Meana[‰] rangeb[abs] |
PCE per 4000 erythrocytesc [abs] [rel] |
||
Vehicle control |
24 |
5 |
2.3 |
7-13 |
2344 |
100% |
Test substance |
24 |
5 |
1.6 |
2-9 |
2069 |
88% |
Test substance |
24 |
5 |
2.3 |
8-12 |
2239 |
96% |
Test substance |
24 |
5 |
1.9 |
3-10 |
1571 |
67% |
Positive control |
24 |
5 |
11.3** |
29-57 |
2644 |
113% |
Vehicle control |
48 |
5 |
1.6 |
4-9 |
2133 |
100% |
Test substance |
48 |
5 |
2.1 |
3-13 |
2235 |
105% |
PCE = polychromatic erythrocytes
NCE = normochromatic erythrocytes
bw. = body weight
a = sum of small and large micronuclei
b = number of micronuclei per animal (sample size: 4000 PCE)
c = calculated number of PCE per 4000 erythrocytes (PCE + NCE) when scoring a sample of up to 20000 PCE per test group
*= p<0.05
**= p<0.01
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.